Staten Island, NY, United States of America

Nick Loizos


 

 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Nick Loizos

Introduction

Nick Loizos is a prominent inventor based in Staten Island, NY. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of three patents to his name, Loizos has focused on innovative solutions for treating neoplastic diseases.

Latest Patents

Loizos's latest patents include groundbreaking inventions aimed at inhibiting tumor growth. One of his notable inventions is the development of antibodies against PDGFRα, which bind to the human PDGFRα receptor and neutralize its activation. This invention provides methods for treating mammals with neoplastic diseases using these antibodies, either alone or in combination with other agents. Another significant patent involves methods of treating secondary bone tumors with PDGFR alpha antagonists, specifically targeting metastatic bone cancer. This invention also outlines methods for treating mammals with neoplastic diseases using these antibodies.

Career Highlights

Throughout his career, Nick Loizos has worked with reputable organizations, including Imclone LLC and the Philadelphia Health and Education Corporation. His work in these companies has allowed him to advance his research and contribute to the development of innovative medical treatments.

Collaborations

Loizos has collaborated with notable professionals in his field, including Jim Huber and Alessandro Fatatis. These collaborations have further enriched his research and development efforts.

Conclusion

Nick Loizos is a distinguished inventor whose work in biotechnology has the potential to significantly impact the treatment of cancer. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…